Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.
about
Raltegravir Pharmacokinetics in Patients on Asunaprevir-DaclatasvirDesign of amphotericin B oral formulation for antifungal therapy.Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.Reduced raltegravir clearance in HIV-infected liver transplant recipients: an unexpected interaction with immunosuppressive therapy?Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient.
P2860
Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Pharmacokinetic study of ralte ...... e: the LIVERAL-ANRS 148 study.
@en
Pharmacokinetic study of ralte ...... e: the LIVERAL-ANRS 148 study.
@nl
type
label
Pharmacokinetic study of ralte ...... e: the LIVERAL-ANRS 148 study.
@en
Pharmacokinetic study of ralte ...... e: the LIVERAL-ANRS 148 study.
@nl
prefLabel
Pharmacokinetic study of ralte ...... e: the LIVERAL-ANRS 148 study.
@en
Pharmacokinetic study of ralte ...... e: the LIVERAL-ANRS 148 study.
@nl
P2093
P2860
P356
P1476
Pharmacokinetic study of ralte ...... e: the LIVERAL-ANRS 148 study.
@en
P2093
Agence Nationale de Recherche sur le Sida et les hépatites (ANRS) 148 Study Group
Anne-Marie Taburet
Caroline Barau
Corine Vincent
Daniel Vittecoq
Elina Teicher
Isabelle Fournier
Jean-Michel Molina
Jean-Pierre Aboulker
Joséphine Braun
P2860
P304
P356
10.1093/CID/CIU515
P407
P577
2014-07-03T00:00:00Z